Drugplain

Clocortolone Pivalate .001 g/g

Clocortolone Pivalate · CREAM · Taro Pharmaceuticals U.S.A., inc.

2 Recalls on Record
Plain English

Clocortolone Pivalate is a cream containing clocortolone pivalate at .001 g/g, taken topical. Manufactured by Taro Pharmaceuticals U.S.A., inc..

Key Facts

Brand Name
Clocortolone Pivalate
Generic Name
Clocortolone Pivalate
NDC Code (Product)
51672-4166
Manufacturer
Taro Pharmaceuticals U.S.A., inc.
Strength
.001 g/g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
ANDA206370
Marketing Start
04/21/2020

Recall History

2 Recalls on Record
Class III03/08/2018

Dr. Reddy's Laboratories, Inc.

Failed Stability Specifications:Out-of-specification results observed for viscosity during stability testing.

TerminatedVoluntary: Firm initiated
Class II04/23/2024

EPI Health, LLC

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

pruritus5 reports
rash5 reports
cardiac disorder3 reports
condition aggravated3 reports
skin exfoliation3 reports
conjunctivitis2 reports
dermatitis atopic2 reports
eczema2 reports
erythema2 reports
palpitations2 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

DOSAGE AND ADMINISTRATION Apply clocortolone pivalate cream USP, 0.1% sparingly to the affected areas three times a day and rub in gently. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate anti-microbial therapy instituted.

Contraindications

CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria

Frequently Asked Questions

What is Clocortolone Pivalate used for?

Clocortolone Pivalate contains Clocortolone Pivalate. It is a cream taken topical. Consult your doctor for specific uses.

Is Clocortolone Pivalate a controlled substance?

Clocortolone Pivalate is not classified as a controlled substance by the DEA.

What is the generic name for Clocortolone Pivalate?

The generic name for Clocortolone Pivalate is Clocortolone Pivalate. There are no other listed brand versions of Clocortolone Pivalate.

What is the NDC code for Clocortolone Pivalate .001 g/g?

The NDC (National Drug Code) for Clocortolone Pivalate .001 g/g is 51672-4166, listed by Taro Pharmaceuticals U.S.A., inc..

Product NDC

51672-4166

Package NDC

51672-4166-6

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)